MSM: Swine Flu Shot May Rely on Emergency Use of Additives

(Bloomberg) – Swine flu vaccine makers may rely on a U.S. emergency declaration to use experimental additives made by GlaxoSmithKline Plc and Novartis AG to boost a limited supply of shots that will be available to fight the pandemic. Continue reading